UW Program for Advanced Cell Therapy has an open position for a Regulatory Scientist. Join a dynamic team led by Jacques Galipeau pushing forward innovative cell therapies for cancer survivors and other disorders. Interested candidates …
UW Program for Advanced Cell Therapy (PACT) secures new FDA IDE to restore innate immunity post allogeneic BMT
On July 2 2024 FDA CBER approved the PACT-sponsored Investigational Device Exemption (IDE) application # 30707 named “Allogeneic, TCR αβ and CD19+ cell-depleted peripheral blood mononuclear cells”. Allogeneic BMT patients receiving post-transplant cyclophosphamide to reduce risk …
PACT Completes Pilot Study of Second Dose of MSC for Dry Mouth
UW Program for Advanced Cell Therapy milestone met of sixth and last pilot study (NCT04489732) subject receiving a second administration of autologous MSC in salivary gland to treat radiation-induced dry mouth. In this pilot study, …
PACT to present at ISCT Annual Meeting Next Week
UW Program for Advanced Cell Therapy sponsored pilot clinical trial update gets oral presentation at ISCT, International Society for Cell & Gene Therapy global meeting in Vancouver on May 30, 2024. The abstract “A pilot, first …
From a MARSH a MSC phoenix may arise
On February 1, 2024, the UW Program for Advanced Cell Therapy sponsored MARSH phase 1 clinical trial treated its first patient at UW Carbone Cancer Center. This National Institute of Dental and Craniofacial Research (NIDCR) …
Wisconsin Senator visits UW SMPH programs advancing cancer cure innovations
On October 3, 2023, Wisconsin Senator Rachael Cabral-Guevara, who Chairs the WI State Legislator Committee on Health, visited UW Health as part of a fact-finding mission on advances in translational cancer research at UW Carbone …
PACT Xerostomia Trial Featured on Spectrum News
PACT Manufacturing Specialist present at ISCT Regional Meeting
Jessica Murphy presented at ISCT, International Society for Cell & Gene Therapy Houston Regional meeting on September 10, 2023, her well received poster and podium presentation of “ALLOGENEIC, LEUKOPHERESIS-DERIVED, VIRUS-SPECIFIC T CELL THERAPY FOR BK …
McCoy, Kimple secure NIDCR funding for MSG MSCs for Xerostomia
UW Program for Advanced Cell Therapy partners Sara McCoy and Randall Kimple secure a new $297,680 National Institute of Dental and Craniofacial Research (NIDCR) R34 award to develop MSG MSC for xerostomia. Entitled “Planning a phase I study of minor salivary gland …
PACT Cell Manufacturing Specialist Presenting at ISCT Regional Meeting
UW Program for Advanced Cell Therapy (PACT) team member Jessica Murphy, MLS, has been selected as an Oral Abstract Presenter at the upcoming ISCT, International Society for Cell & Gene Therapy North America 2023 Houston Meeting, Sept 8-10 https://lnkd.in/ghq84Wsj, …